Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins
    2.
    发明申请
    Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins 审中-公开
    组合物,接头变体和与癌症特异性基因和蛋白质相关的方法

    公开(公告)号:US20080260761A1

    公开(公告)日:2008-10-23

    申请号:US11576554

    申请日:2005-10-04

    CPC classification number: C07K14/4748 A61K38/00

    Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic ovarian cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovarian, identifying ovarian tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovarian tissue for treatment and research.

    Abstract translation: 本发明涉及存在于正常和肿瘤性卵巢细胞中的新鉴定的核酸分子和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及含有本发明的核酸分子,多肽,抗体,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括鉴定,诊断,监测,分期,成像和治疗卵巢癌和非癌性疾病状态,确定卵巢组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的生产,以及用于治疗和研究的工程化卵巢组织的生产。

    Compositions, splice variants and methods relating to cancer specific genes and proteins
    3.
    发明申请
    Compositions, splice variants and methods relating to cancer specific genes and proteins 审中-公开
    与癌症特异性基因和蛋白质有关的组合物,剪接变体和方法

    公开(公告)号:US20060078913A1

    公开(公告)日:2006-04-13

    申请号:US11183261

    申请日:2005-07-15

    CPC classification number: C07K14/4748 G01N33/57484

    Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast, intestine and colon, lung, ovarian or prostate cancer and non-cancerous disease states in breast, intestine and colon, lung, ovarian or prostate, identifying breast, intestine and colon, lung, ovarian or prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast, intestine and colon, lung, ovarian or prostate tissue for treatment and research.

    Abstract translation: 本发明涉及存在于正常和肿瘤细胞中的新鉴定的核酸分子和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及含有本发明的核酸分子,多肽,抗体,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括在乳腺,肠和结肠,肺,卵巢或前列腺中识别,诊断,监测,分期,成像和治疗乳腺,肠和结肠,肺,卵巢或前列腺癌和非癌性疾病状态,鉴定乳腺,肠和 结肠,肺,卵巢或前列腺组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的产生以及工程乳房,肠和结肠,肺,卵巢或前列腺组织的生产用于治疗和研究。

    Catheter Stabilizing Device
    4.
    发明申请

    公开(公告)号:US20220062589A1

    公开(公告)日:2022-03-03

    申请号:US17009058

    申请日:2020-09-01

    Abstract: A catheter stabilizing device for stabilizing a Continuous Ambulatory Peritoneal Dialysis (CAPD) catheter includes a pad having an adhesive engaged to a first face thereof. The adhesive is used to engage the pad to abdominal skin of a user so that the pad is engaged to an abdomen of the user. A connector is engaged to a second face of the pad and can selectively connect to a tube of a catheter. The connector stabilizes the catheter in a selected position.

    Compositions, splice variants and methods relating to cancer specific genes and proteins
    5.
    发明申请
    Compositions, splice variants and methods relating to cancer specific genes and proteins 审中-公开
    与癌症特异性基因和蛋白质有关的组合物,剪接变体和方法

    公开(公告)号:US20050272067A1

    公开(公告)日:2005-12-08

    申请号:US11077386

    申请日:2005-03-10

    CPC classification number: C07K14/4748

    Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast, intestine and colon, lung, ovarian or prostate cancer and non-cancerous disease states in breast, intestine and colon, lung, ovarian or prostate, identifying breast, intestine and colon, lung, ovarian or prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast, intestine and colon, lung, ovarian or prostate tissue for treatment and research.

    Abstract translation: 本发明涉及存在于正常和肿瘤细胞中的新鉴定的核酸分子和多肽,包括核酸和多肽的片段,变体和衍生物。 本发明还涉及本发明多肽的抗体,以及本发明多肽的激动剂和拮抗剂。 本发明还涉及含有本发明的核酸分子,多肽,抗体,激动剂和拮抗剂以及使用这些组合物的方法的组合物。 这些用途包括在乳腺,肠和结肠,肺,卵巢或前列腺中识别,诊断,监测,分期,成像和治疗乳腺,肠和结肠,肺,卵巢或前列腺癌和非癌性疾病状态,鉴定乳腺,肠和 结肠,肺,卵巢或前列腺组织,监测和鉴定和/或设计本发明多肽的激动剂和拮抗剂。 用途还包括基因治疗,转基因动物和细胞的产生以及工程乳房,肠和结肠,肺,卵巢或前列腺组织的生产用于治疗和研究。

Patent Agency Ranking